December 10, 2024 - 23:28

French political turmoil has driven uncertainty in industry and construction to levels not seen since the energy crisis in 2022, extending a shadow over the country’s economic outlook. The ongoing unrest has raised concerns among business leaders, who fear that instability could hinder investment and growth. Many companies are now reassessing their strategies in light of the volatile political climate, with some delaying projects or scaling back operations.
The construction sector, in particular, has been hit hard, as rising costs and supply chain disruptions compound the challenges posed by political instability. Industry experts warn that prolonged uncertainty could lead to job losses and reduced economic activity, further complicating the recovery from past crises.
As the government grapples with public discontent and calls for reform, the business community is left to navigate an increasingly complex landscape. The hope remains that a resolution can be found soon, allowing for a more stable environment conducive to economic growth and confidence.
June 23, 2026 - 06:50
OCBC Boosts Hiring for Indonesia Wealth Business as Assets RiseOversea-Chinese Banking Corp. is stepping up its presence in Indonesia by planning to double the number of wealth advisers in the country. The move is part of a wider expansion strategy following...
June 22, 2026 - 21:55
Why a Strong Business Plan Gives You a Real Leadership EdgeMany entrepreneurs treat business plans as a chore. They rush through the financial projections, copy-paste market analysis from competitors, and call it done. But that approach misses the point...
June 22, 2026 - 00:57
Teen on Kauaʻi with Down Syndrome turns beach sand messages into businessA simple family tradition on the shores of Kauai has grown into a real business for a young woman with Down syndrome. Katrina Louise Martinez and her daughter, Ella Joy Martinez, started writing...
June 21, 2026 - 08:56
Bigger, fewer, tougher: the new era of China-US biotech partnershipsChina`s biotechnology sector remains a magnet for Western pharmaceutical giants, despite the United States government tightening its grip on technology transfers and cross-border investments. The...